Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Patrick Kateete

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
AI/ML-based prediction of TB treatment failure: A systematic review and meta-analysisRogers Kamulegeya, Rose Nabatanzi, Derrick Semugenze, et al.
Scientific Reports|March 27, 2025
Isoniazid preventive therapy modulates Mycobacterium tuberculosis-specific T-cell responses in individuals with latent tuberculosis and type 2 diabetesPhillip Ssekamatte, Diana Sitenda, Rose Nabatanzi, et al.
Antimicrobial Resistance and Infection Control|June 8, 2019
CA-MRSA and HA-MRSA coexist in community and hospital settings in UgandaDavid Patrick Kateete, Freddie Bwanga, Jeremiah Seni, et al.
Livers|August 22, 2025
Serological Status of Vaccine and Hepatitis B Virus Exposure Among Children Under 5 and Aged 15-17 Years in Kampala, UgandaFahad Muwanda, Edward Kiyonga, Joan Nambafu, et al.
Neurotrauma Reports|October 11, 2024
Timing of Surgery and Preoperative Predictors of Surgical Site Infections for Patients with Depressed Skull Fractures in a Sub-Saharan Tertiary Hospital: A Prospective Cohort StudyHervé Monka Lekuya, Jelle Vandersteene, Larrey Kasereka Kamabu, et al.
BMC Immunology|November 7, 2025
A quadral biosignature of IFN-γ, IL-2, IL-12 and IP-10 increases the diagnostic potential for latent tuberculosis among diabetic patients in UgandaPhillip Ssekamatte, Diana Sitenda, Rose Nabatanzi, et al.
Frontiers in Immunology|October 21, 2024
Impaired <i>Mycobacterium tuberculosis</i>-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in UgandaPhillip Ssekamatte, Rose Nabatanzi, Diana Sitenda, et al.
BMC Pulmonary Medicine|July 12, 2019
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016)David Patrick Kateete, Rogers Kamulegeya, Edgar Kigozi, et al.
Therapeutic Advances in Infectious Disease|May 30, 2024
Distribution and antifungal susceptibility profile of oropharyngeal <i>Candida</i> species isolated from people living with HIV in the era of universal test and treat policy in UgandaMusinguzi Benson, Laban Turyamuhika, Alex Mwesigwa, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2019
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in UgandaJonah Omooja, Maria Nannyonjo, Grace Sanyu, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
AI/ML-based prediction of TB treatment failure: A systematic review and meta-analysisRogers Kamulegeya, Rose Nabatanzi, Derrick Semugenze, et al.
Scientific Reports|March 27, 2025
Isoniazid preventive therapy modulates Mycobacterium tuberculosis-specific T-cell responses in individuals with latent tuberculosis and type 2 diabetesPhillip Ssekamatte, Diana Sitenda, Rose Nabatanzi, et al.
Antimicrobial Resistance and Infection Control|June 8, 2019
CA-MRSA and HA-MRSA coexist in community and hospital settings in UgandaDavid Patrick Kateete, Freddie Bwanga, Jeremiah Seni, et al.
Livers|August 22, 2025
Serological Status of Vaccine and Hepatitis B Virus Exposure Among Children Under 5 and Aged 15-17 Years in Kampala, UgandaFahad Muwanda, Edward Kiyonga, Joan Nambafu, et al.
Neurotrauma Reports|October 11, 2024
Timing of Surgery and Preoperative Predictors of Surgical Site Infections for Patients with Depressed Skull Fractures in a Sub-Saharan Tertiary Hospital: A Prospective Cohort StudyHervé Monka Lekuya, Jelle Vandersteene, Larrey Kasereka Kamabu, et al.
BMC Immunology|November 7, 2025
A quadral biosignature of IFN-γ, IL-2, IL-12 and IP-10 increases the diagnostic potential for latent tuberculosis among diabetic patients in UgandaPhillip Ssekamatte, Diana Sitenda, Rose Nabatanzi, et al.
Frontiers in Immunology|October 21, 2024
Impaired <i>Mycobacterium tuberculosis</i>-specific T-cell memory phenotypes and functional profiles among adults with type 2 diabetes mellitus in UgandaPhillip Ssekamatte, Rose Nabatanzi, Diana Sitenda, et al.
BMC Pulmonary Medicine|July 12, 2019
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016)David Patrick Kateete, Rogers Kamulegeya, Edgar Kigozi, et al.
Therapeutic Advances in Infectious Disease|May 30, 2024
Distribution and antifungal susceptibility profile of oropharyngeal <i>Candida</i> species isolated from people living with HIV in the era of universal test and treat policy in UgandaMusinguzi Benson, Laban Turyamuhika, Alex Mwesigwa, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2019
Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in UgandaJonah Omooja, Maria Nannyonjo, Grace Sanyu, et al.
Pageof 8